Expression of HLA-DP0401 molecules for identification of DP0401 restricted antigen specific T cells
- PMID: 16160911
- DOI: 10.1007/s10875-005-6095-6
Expression of HLA-DP0401 molecules for identification of DP0401 restricted antigen specific T cells
Abstract
Human histocompatibility leukocyte antigen (HLA)-DPA1*0103/DPB1*0401 (DP0401) is the most common HLA class II molecule and is present in approximately 45% of the Caucasian population. In this study, soluble HLA-DP0401 molecules were expressed as "empty'' class II molecules in insect cells. Utilizing these soluble DP molecules and the Tetramer Guided Epitope Mapping (TGEM) approach, the influenza A Puerto Rico/8/34 matrix protein (MP) derived peptide MP(41-60) VLMEWLKTRPILSPLTKGIL and the Clostridium tetani Tetanus Toxin (TT) derived peptide TT(634-653) DKISDVSTIVPYIGPALNIV were identified as the DP0401 restricted MP and TT epitopes, respectively. In addition, T cells specific for the cancer testis antigen NY-ESO-1 and the breast/ovarian cancer over-expressing antigen Her-2/neu were detected in DP0401 subjects by DP0401 tetramers. The availability of HLA-DP0401 tetramers should facilitate the study of DP restricted T cell responses.
Similar articles
-
One NY-ESO-1-derived epitope that promiscuously binds to multiple HLA-DR and HLA-DP4 molecules and stimulates autologous CD4+ T cells from patients with NY-ESO-1-expressing melanoma.J Immunol. 2005 Feb 1;174(3):1751-9. doi: 10.4049/jimmunol.174.3.1751. J Immunol. 2005. PMID: 15661941
-
Generation of NY-ESO-1-specific CD4+ and CD8+ T cells by a single peptide with dual MHC class I and class II specificities: a new strategy for vaccine design.Cancer Res. 2002 Jul 1;62(13):3630-5. Cancer Res. 2002. PMID: 12097265 Free PMC article.
-
Efficient presentation of known HLA class II-restricted MAGE-A3 epitopes by dendritic cells electroporated with messenger RNA encoding an invariant chain with genetic exchange of class II-associated invariant chain peptide.Cancer Res. 2003 Sep 1;63(17):5587-94. Cancer Res. 2003. PMID: 14500399
-
Use of HLA class II tetramers in tracking antigen-specific T cells and mapping T-cell epitopes.Methods. 2003 Mar;29(3):282-8. doi: 10.1016/s1046-2023(02)00350-x. Methods. 2003. PMID: 12725793 Review.
-
Mechanisms of HLA-DP Antigen Processing and Presentation Revisited.Trends Immunol. 2018 Dec;39(12):960-964. doi: 10.1016/j.it.2018.10.008. Epub 2018 Nov 8. Trends Immunol. 2018. PMID: 30416081 Review.
Cited by
-
Immunodominant CD4+ T-cell responses to influenza A virus in healthy individuals focus on matrix 1 and nucleoprotein.J Virol. 2014 Oct;88(20):11760-73. doi: 10.1128/JVI.01631-14. Epub 2014 Jul 30. J Virol. 2014. PMID: 25078703 Free PMC article.
-
Cross-reactive and mono-reactive SARS-CoV-2 CD4+ T cells in prepandemic and COVID-19 convalescent individuals.PLoS Pathog. 2021 Dec 29;17(12):e1010203. doi: 10.1371/journal.ppat.1010203. eCollection 2021 Dec. PLoS Pathog. 2021. PMID: 34965282 Free PMC article.
-
Role of HLA-DP in the Presentation of Epitopes from the Truncated Bacterial PE38 Immunotoxin.AAPS J. 2017 Jan;19(1):117-129. doi: 10.1208/s12248-016-9986-y. Epub 2016 Oct 27. AAPS J. 2017. PMID: 27796910 Free PMC article.
-
HLA-DR and HLA-DP restricted epitopes from human cytomegalovirus glycoprotein B recognized by CD4+ T-cell clones from chronically infected individuals.J Clin Immunol. 2012 Dec;32(6):1305-16. doi: 10.1007/s10875-012-9732-x. Epub 2012 Jul 15. J Clin Immunol. 2012. PMID: 22797815 Free PMC article.
-
Class II major histocompatibility complex tetramer staining: progress, problems, and prospects.Immunology. 2008 Mar;123(3):305-13. doi: 10.1111/j.1365-2567.2007.02801.x. Immunology. 2008. PMID: 18251991 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous